Vaccine Scheduler

Pertussis: Recommended vaccinations

	General recommendation
	Recommendation for specific groups only
	Catch-up (e.g. if previous doses missed)
	Vaccination not funded by the National Health system
	Mandatory vaccination

	Months														Years
	2	3	4	5	6	8	10	11	12	13	15	16	18	19-20	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16	17	18	19	20	25	45	60	≥ 61
Austria		acP	acP					acP¹												acP									acp²								acp³

Belgium	acP	acP	acP								acP							acP									acp				acp⁴

Bulgaria	acP	acP	acP									acP⁵							acP						acp

Croatia	acP		acP		acP						acP								acP⁶												acp⁷

Cyprus	acP		acP		acP								acP				acP							acp							acp⁸

Czechia		acP⁹	acP					acP										acp					acp								acp¹⁰

Denmark		acP		acP					acP									acP													acp¹¹

Estonia		acP	acP		acP										acP				acP									acp

Finland		acP		acP					acP								acP										acp							acp

France	acP¹²		acP					acP											acP					acp										acp¹³

Germany	acP	acP	acP					acP	acP									acp				acp									acp¹⁴

Greece	acP		acP		acP				acP		acp			acp			acP			acp				acp		acp						acp¹⁵

Hungary	acP	acP	acP										acP						acP					acp¹⁶							acp¹⁷

Iceland		acP		acP					acP								acp										acp¹⁸				acp¹⁹

Ireland	acP		acP		acP												acP								acp²⁰						acp²¹

Italy	acP		acP				acP											acP							acp							acp²²

Latvia	acP		acP		acP				acP											acP²³							acp				acp²⁴

Liechtenstein	acP		acP						acP								acP²⁵				acp			acp										acp²⁶

Lithuania	acP		acP		acP								acP						acP									acp			acp²⁷

Luxembourg	acP	acP²⁸	acP					acP										acP										acP²⁹						acp³⁰

Malta	acP	acP	acP										acp

Netherlands	acP³¹	acP		acP					acP								acP														acp³²

Norway		acP		acP					acP											acP								acP						acp³³

Poland	wcP³⁴	wcP³⁴		wcP³⁴								wcP³⁴							acP								acp					acp³⁵

Portugal	acP		acP		acP								acP					acP													acp³⁶

Romania	acP		acP					acP											acP								acp				acp¹⁹

Slovakia	acP		acP				acP											acP							acP

Slovenia		acP		acP				acP													acP							acp³⁷			acp³⁸

Spain	acP³⁹		acP³⁹					acP³⁹											acp⁴⁰												acp⁴¹

Sweden		acP		acP					acP									acP									acp⁴²				acp⁴³

Footnotes:

Minimum interval of 6 month after second dose
dTaP-IPV every 10 years. Vaccination of pregnant women recommended but not funded, preferably in the 3rd trimester (27th-36th week of pregnancy), independent from the interval to the last vaccination against pertussis.
dTaP every 5 years
One dose of dTTaP every 10 years for adults after receiving the childhood immunisation schedule. Vaccination of expectant mothers during every pregnancy with a pertussis-containing vaccine in week 24 to week 32 of pregnancy. dTTaP boosters are funded for all pregnant women nationally. However, these booster doses are only offered for free in other adults in Flanders region.
Not earlier than 12 months after the 3rd dose
DTaP or dTap.
Temporary recommendation in response to the current pertusiss epidemic, Tdacp vaccination of all pregnant women in the second and third trimester and also vaccination of all close contacts of the newborn („cooconing“).
Vaccination offered to pregnant women (one dose in each pregnancy). More information available at: NATIONAL VACCINATION PROGRAM FOR ADULTS AND RISK GROUPS 15 2 2024.pdf (moh.gov.cy)
The first dose of hexavalent vaccine is given from the end of the 2nd month of life, at intervals of two months between the first and the second dose, and the third dose given between the eleventh and thirteenth months of the child's age
One booster dose in adulthood is recommended, 10 to 15 years after the last dose. Pertussis vaccination is also recommended for pregnant women from the 27th gestational week. Vaccination is recommended at every pregnancy.
Vaccination during pregnancy. see https://www.ssi.dk/vaccinationer/risikogrupper/gratis-kighostevaccination-til-gravide
or 8 weeks of age
For those who did not receive a dose of pertussis containing vaccine during the past 5 years, a booster with a quadrivalent vaccine (dTacp-IPV) is recommended at the time of the Td-IPV booster at 25 years. For those aged 25 years and above that did not receive a booster dose, catch-up with a dTacp-IPV vaccine can be proposed until 39 years of age. Recommendation to have an interval of 10 years in adults between a documented pertussis and pertussis re-vaccination. Vaccination offered to pregnant women from 2nd trimester and preferably between 20 and 36 weeks of pregnancy. More information available at: calendrier_vaccinal_maj-juin23.pdf (sante.gouv.fr)
The next due Td 10-yearly booster dose should be with a Tdacp vaccine. Subsequent booster doses are to be done with Td vaccines. Vaccination offered to pregnant women at the beginning of 3rd trimester. If there is an increased probability of premature birth, vaccination should be brought forward to the 2nd trimester. More information available at: RKI - Vaccinations A - Z - Scientific justification for recommending pertussis vaccination with a Tdap combination vaccine in pregnancy
Td booster every 10 years. One of the booster dose should be with Tdacp or Tdacp-IPV. A single dose of Tdacp or Tdacp-IPV vaccine should be administered in each pregnancy, preferably from 27 to 36 weeks of gestation, as well as to unvaccinated women who have recently given birth, regardless of the interval between previous Tdacp vaccination.
School-based vaccination in 6th grade (mandatory)
Vaccination offered to pregnant women between 16 and 32 weeks of pregnancy. More information available at: Vacsatc - Vaccine safety | Professional sites | Vaccination methodology letter 2023
Repeat for pregnant women in second or third trimester of every pregnancy regardless of the time since last vaccination.
Vaccination during pregnancy
Booster dose
Tdap - Vaccination for pregnant women between 16-36 weeks gestation.
Tdap is recommended every 10 years from age 19, and also for pregnant women in the third trimester (ideally 28 weeks)
Six-year-old children may be vaccinated with vaccinations for 7-year-old children, if the child is beginning to study in an educational institution.
Pertussis antigen during pregnancy
A lower dose of diphtheria toxoid (d) and whooping cough (ap) can also be used (dTap) The pertussis booster provided between the ages of 4 and 7 years should be administered no later than school entry.
Booster at 25 years (dTap), 45 years (dT) and 65 years (dT), and then every 10 years (dT)
Vaccination during pregnancy (introduced March 2023)
For premature infants (born before 33 weeks) or with a birthweight <1500g, a 3+1 schedule is recommended
One booster dose of Tdacp-IPV in this age group.
One booster dose every 10 years. Vaccination for pregnant women between 13-26 weeks gestation - Tdap or TdapIPV vaccine
In the Netherlands, two primary doses (at 3 and 5 months) are provided for infants born from mothers who were vaccinated during pregnancy (at 22 weeks gestation). An additional vaccination is given at 2 months if the mother is not vaccinated during pregnancy.
Recommended for pregnant women from 22 weeks gestation
Revaccination every 10 years. Recommendation for vaccination during pregnancy in week 24, but catch-up vaccination can be accommodated until birth. More information available at: https://www.fhi.no/va/kikhostevaksine-til-gravide/ and https://www.fhi.no/contentassets/944632814cbc4260bac97a49924b7884/vedlegg/infoark-engelsk-kikhostevaksine-gravide.pdf
An acellular pertussis component (aP) combination vaccine should be used for children with contraindications to vaccination with the whole cell pertussis vaccine and in children born before 37th week of pregnancy or born with birth weight less than 2500 g
One booster doses every 10 years is recommended.Vaccination offered to pregnant women between 27 and 36 weeks of pregnancy and ideally between 28 and 32 weeks of pregnancy. More information available at: Kalendarz szczepien 2023 Kobiet w ciazy (pzh.gov.pl) and https://szczepienia.pzh.gov.pl/kalendarz-szczepien-doroslych/
Tdap vaccination recommended during pregnancy in all ages between 20 to 36 weeks of gestation
From 2023 onwards, TT was replaced by dTacp
Pregnant women: 1 dose Tdap vaccine recommended from the 24th week of pregnancy. see https://nijz.si/nalezljive-bolezni/cepljenje/cepljenje-nosecnic/
For more detail on review and recommendation for pertussis vaccination in Spain, please refer to https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/comoTrabajamos/difteria-tetanos-tosferina.htm
For more detail on review and recommendation for pertussis vaccination in Spain, please refer to https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/comoTrabajamos/docs/TosFerina.pdf
Repeat for pregnant women starting from week 27 of the pregnancy (preferably at week 27 or 28).
Given to 8-9 grade students.
Vaccination offered to pregnant women after 16 weeks of pregnancy. More information available at: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/vaccinationer-till-vuxna/